The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity

por Reddy, Mamatha M., Fernandes, Margret S., Deshpande, Anagha, Weisberg, Ellen, Inguilizian, Haig V., Abdel-Wahab, Omar, Kung, Andrew L., Levine, Ross L., Griffin, James D., Sattler, Martin
Publicado 2011

A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

por Kim, Richard, Leal, Alexis D., Parikh, Aparna, Ryan, David P., Wang, Shining, Bahamon, Brittany, Gupta, Neeraj, Moss, Aaron, Pye, Joanna, Miao, Harry, Inguilizian, Haig, Cleary, James M.
Publicado 2023

Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

por Kim, Richard, Leal, Alexis D., Parikh, Aparna, Ryan, David P., Wang, Shining, Bahamon, Brittany, Gupta, Neeraj, Moss, Aaron, Pye, Joanna, Miao, Harry, Inguilizian, Haig, Cleary, James M.
Publicado 2023